MEETINGS - US coronary drug-eluting stents regulatory workshop
This article was originally published in Clinica
Executive Summary
US medtech industry association AdvaMed and the FDA are holding a joint workshop to clarify the draft recommendations issued by the agency last month on "coronary drug-eluting stents, non-clinical and clinical studies. The event takes place on April 29 at the FDA's White Oak Campus, in Silver Spring, Maryland. The deadline for registration of non-US attendees as visitors was April 11. Further information and registration via the meetings and events pages of www.advamed.org